Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Andrew Embleton
The Cost-Effectiveness of Bevacizumab in Advanced Ovarian Cancer Using Evidence From the ICON7 Trial
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Bevacizumab in the Treatment of Ovarian Cancer
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Cost-Effectiveness of the Family Nurse Partnership (FNP) Programme in England: Evidence From the Building Blocks Trial
Journal of Evaluation in Clinical Practice
Health Policy
Public Health
Occupational Health
Environmental
Bevacizumab for Metastatic Colorectal Cancer: A Global Cost‐Effectiveness Analysis
Oncologist
Cancer Research
Medicine
Oncology
Evidence for the Role of Bevacizumab in the Treatment of Advanced Metastatic Breast Cancer: A Review
Breast Cancer: Targets and Therapy
Oncology
PROFAST: ERAS in Advanced Ovarian Cancer, a Randomised Trial
Clinical Nutrition ESPEN
Endocrinology
Nutrition
Metabolism
Dietetics
Diabetes
Evidence From Cost-Effectiveness Research
NeuroRX
Bevacizumab in the Treatment of Nonsquamous Non-Small Cell Lung Cancer: Clinical Trial Evidence and Experience
Therapeutic Advances in Respiratory Disease
Pulmonary
Respiratory Medicine
Pharmacology
Cost‐effectiveness of the Collaborative Care to Preserve Performance in Cancer (COPE) Trial Tele‐rehabilitation Interventions for Patients With Advanced Cancers
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
The Epidemiology of CA-125 in Women Without Evidence of Ovarian Cancer in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial
Gynecologic Oncology
Gynecology
Oncology
Obstetrics
